IV

Indrayani Vijay Chimote

Active Director Director DIN 01677269
DIN 01677269 First appointment Jun 2004 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Indrayani Vijay Chimote

Data last updated:

Indrayani Vijay Chimote is a Director at Anushka Medical Foundation And Research Institute Limited (since 2004). The company operates in Healthcare.

DIN 01677269
Primary Designation Director
Industry Healthcare
First Appointment 09 Jun 2004
Oldest Company Age 22 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20042004Active

Board colleagues of Indrayani Vijay Chimote

Directorship timeline

Open interactive timeline →
Anushka Medical Foundation And Research Institute Limited
Premium access

Shareholding and investment profile for Indrayani Vijay Chimote

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indrayani Vijay Chimote

Indrayani Vijay Chimote currently holds 1 directorship: Anushka Medical Foundation And Research Institute Limited (Director, since 09 Jun 2004).

Indrayani Vijay Chimote was first appointed on 09 Jun 2004 as Director at Anushka Medical Foundation And Research Institute Limited.

The current boards of Indrayani Vijay Chimote's companies include Ajay Chimote (Anushka Medical Foundation And Research Institute Limited), Vijay Chimote (Anushka Medical Foundation And Research Institute Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available